These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17040215)

  • 1. Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin.
    Härtter S; Korhonen T; Lundgren S; Rane A; Tolonen A; Turpeinen M; Laine K
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):300-4. PubMed ID: 17040215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study.
    Härtter S; Ursing C; Morita S; Tybring G; von Bahr C; Christensen M; Röjdmark S; Bertilsson L
    Clin Pharmacol Ther; 2001 Jul; 70(1):10-6. PubMed ID: 11452239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism.
    Hilli J; Korhonen T; Turpeinen M; Hokkanen J; Mattila S; Laine K
    J Clin Pharmacol; 2008 Aug; 48(8):986-94. PubMed ID: 18490497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of CYP1A2 activity in clinical practice: why, how, and when?
    Faber MS; Jetter A; Fuhr U
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):125-34. PubMed ID: 16128905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity.
    Härtter S; Nordmark A; Rose DM; Bertilsson L; Tybring G; Laine K
    Br J Clin Pharmacol; 2003 Dec; 56(6):679-82. PubMed ID: 14616429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
    Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
    Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension.
    Palatini P; Ceolotto G; Ragazzo F; Dorigatti F; Saladini F; Papparella I; Mos L; Zanata G; Santonastaso M
    J Hypertens; 2009 Aug; 27(8):1594-601. PubMed ID: 19451835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers.
    Pavanello S; Pulliero A; Lupi S; Gregorio P; Clonfero E
    Mutat Res; 2005 Nov; 587(1-2):59-66. PubMed ID: 16188490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.
    Nakajima M; Yokoi T; Mizutani M; Shin S; Kadlubar FF; Kamataki T
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):413-21. PubMed ID: 7920209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole weakly inhibits CYP1A2 activity in man.
    Rost KL; Fuhr U; Thomsen T; Zaigler M; Brockmöller J; Bohnemeier H; Roots I
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):567-74. PubMed ID: 10584979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss.
    Sata F; Yamada H; Suzuki K; Saijo Y; Kato EH; Morikawa M; Minakami H; Kishi R
    Mol Hum Reprod; 2005 May; 11(5):357-60. PubMed ID: 15849225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.
    Han XM; Ouyang DS; Chen XP; Shu Y; Jiang CH; Tan ZR; Zhou HH
    Br J Clin Pharmacol; 2002 Nov; 54(5):540-3. PubMed ID: 12445035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
    Kotsopoulos J; Ghadirian P; El-Sohemy A; Lynch HT; Snyder C; Daly M; Domchek S; Randall S; Karlan B; Zhang P; Zhang S; Sun P; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):912-6. PubMed ID: 17507615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis.
    Tian DD; Natesan S; White JR; Paine MF
    Clin Transl Sci; 2019 Jan; 12(1):39-46. PubMed ID: 30387917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a CYP1A2 polymorphism on post-exercise heart rate variability in response to caffeine intake: a double-blind, placebo-controlled trial.
    Thomas RM; Algrain HA; Ryan EJ; Popojas A; Carrigan P; Abdulrahman A; Carrillo AE
    Ir J Med Sci; 2017 May; 186(2):285-291. PubMed ID: 27363424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the possibility of patient phenotyping on the basis of cytochrome p-450 1A2 isoenzyme activity using caffeine as the test substrate].
    Filimonova AA; Ziganshina LE; Ziganshin AU; Chichirov AA
    Eksp Klin Farmakol; 2009; 72(5):61-5. PubMed ID: 19928580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correspondence re: letter to the editor by B. K. Tang and W. Kalow on CYP1A2 phenotyping using caffeine. Cancer Epidemiol. Biomarkers & Prev., 5: 231, 1996.
    Kadlubar FF; Young JF; Lang NP; Caporaso NE; Sinha R; Landi MT
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):757-8. PubMed ID: 8877069
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients.
    Raaska K; Raitasuo V; Laitila J; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2004 Jan; 94(1):13-8. PubMed ID: 14725610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia.
    Tay JK; Tan CH; Chong SA; Tan EC
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1297-302. PubMed ID: 17611010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.
    Chen Y; Tu JH; He YJ; Zhang W; Wang G; Tan ZR; Zhou G; Fan L; Zhou HH
    Xenobiotica; 2009 Jul; 39(7):508-13. PubMed ID: 19534587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.